1. Home
  2. PMT vs EVO Comparison

PMT vs EVO Comparison

Compare PMT & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PennyMac Mortgage Investment Trust of Beneficial Interest

PMT

PennyMac Mortgage Investment Trust of Beneficial Interest

HOLD

Current Price

$9.66

Market Cap

879.9M

Sector

Real Estate

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.92

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMT
EVO
Founded
2009
1993
Country
United States
Germany
Employees
7
4553
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
879.9M
1.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PMT
EVO
Price
$9.66
$1.92
Analyst Decision
Hold
Strong Buy
Analyst Count
5
1
Target Price
$13.50
$7.00
AVG Volume (30 Days)
1.7M
45.5K
Earning Date
05-05-2026
04-08-2026
Dividend Yield
13.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
$1.55
$10.05
P/E Ratio
$12.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.56
$1.94
52 Week High
$13.80
$4.32

Technical Indicators

Market Signals
Indicator
PMT
EVO
Relative Strength Index (RSI) 39.29 25.42
Support Level N/A N/A
Resistance Level $12.26 $3.36
Average True Range (ATR) 0.25 0.09
MACD -0.06 -0.04
Stochastic Oscillator 9.91 1.51

Price Performance

Historical Comparison
PMT
EVO

About PMT PennyMac Mortgage Investment Trust of Beneficial Interest

PennyMac Mortgage Investment Trust is a specialty finance company that invests mainly in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: